^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    GENE:

    MED14OS (MED14 Opposite Strand)

    i
    Other names: MED14OS, MED14 Opposite Strand, MED14-AS1, MED14 Antisense Gene Protein 1, MED14 Opposite Strand Protein, MED14 Antisense RNA 1, MED14 Antisense RNA 1, Putative Uncharacterized Protein MED14OS, NONHSAG054279.2, HSALNG0137432, Lnc-MPC1L-1
    Associations

    News

    Trials
    3ms
    Migrasome-related LncRNA features predict immune microenvironment and prognosis in pancreatic cancer. (PubMed, Sci Rep)
    The results of this study construct a predictive model of pancreatic cancer associated with migrasome, and clarify the relevance of this model to immunotherapy and so on. It provides a new idea for improving immunotherapy and drug therapy.
    Journal • Tumor mutational burden • IO biomarker
    |
    TMB (Tumor Mutational Burden) • MED14OS (MED14 Opposite Strand)
    over2years
    An angiogenesis-related lncRNA signature predicts the immune microenvironment and prognosis of breast cancer. (PubMed, Aging (Albany NY))
    Taken together, we constructed and verified a robust signature of eight ARLs for the prediction of survival in patients with breast cancer, and the characterization of the immune infiltration landscape. Our findings suggest that OTUD6B-AS1 could be a therapeutic target for patients with breast cancer.
    Journal • Tumor mutational burden
    |
    TMB (Tumor Mutational Burden) • OTUD6B (OTU Deubiquitinase 6B) • CYTOR (Cytoskeleton Regulator RNA) • MED14OS (MED14 Opposite Strand) • MILIP (MYC Inducible LncRNA Inactivating P53) • OTUD6B-AS1 (OTUD6B Antisense RNA 1) • SNHG10 (Small Nucleolar RNA Host Gene 10)